INTERLINK-1: A Phase III, Randomized, Placebo-Controlled Study of Monalizumab plus Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell CarcinomaJérôme Fayette, Helena Rebelo‐de‐Andrade, Lillian L. Siu et al.|Clinical Cancer Research|2025Cited by 26
Supplementary Data 1 from INTERLINK-1: A Phase III, Randomized, Placebo-Controlled Study of Monalizumab plus Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell CarcinomaJérôme Fayette, Jan Paul de Boer, Lisa Licitra et al.|Unknown|2025Cited by 0